Issued Patents All Time
Showing 1–25 of 54 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391676 | BRD4-JAK2 inhibitors | Ernst Schönbrunn, Harshani R. Lawrence, Gary Reuther | 2025-08-19 |
| 12233054 | Dimeric immuno-modulatory compounds against cereblon-based mechanisms | Pearlie Burnette, Harshani R. Lawrence | 2025-02-25 |
| 12187686 | BRD4-JAK2 inhibitors | Ernst Schönbrunn, Harshani R. Lawrence, Gary Reuther | 2025-01-07 |
| 12060332 | Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease | Brian Betts, Said M. Sebti, Harshani R. Lawrence, Claudio Anasetti, Joseph Pidala | 2024-08-13 |
| 11999695 | YAP1 inhibitors that target the interaction of YAP1 with OCT4 | Srikumar Chellappan, Sujeewa Ranatunga Mahanthe Mudiyanselage | 2024-06-04 |
| 11987568 | Allosteric inhibitor of WEE1 kinase | Nupam P. Mahajan | 2024-05-21 |
| 11730726 | Dimeric immuno-modulatory compounds against cereblon-based mechanisms | Pearlie Burnette, Harshani R. Lawrence | 2023-08-22 |
| 11685725 | YAP1 inhibitors that target the interaction of YAP1 with OCT4 | Srikumar Chellappan, Sujeewa Ranatunga Mahanthe Mudiyanselage | 2023-06-27 |
| 11643396 | BRD4-kinase inhibitors as cancer therapeutics | Ernst Schönbrunn, Harshani R. Lawrence | 2023-05-09 |
| 11571418 | Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells | Said M. Sebti, James Turkson | 2023-02-07 |
| 11530182 | YAP1 inhibitors that target the interaction of YAP1 with Oct4 | Srikumar Chellappan, Sujeewa Ranatunga Mahanthe Mudiyanselage | 2022-12-20 |
| 11395820 | Small molecules against cereblon to enhance effector t cell function | Pearlie Burnette, Harshani R. Lawrence | 2022-07-26 |
| 11203576 | Aurora kinase and Janus kinase inhibitors for prevention of graft versus host disease | Brian Betts, Said M. Sebti, Harshani R. Lawrence, Claudio Anasetti, Joseph Pidala | 2021-12-21 |
| 10954258 | STAT3 dimerization inhibitors | Said M. Sebti, Harshani R. Lawrence | 2021-03-23 |
| 10906874 | YAP1 inhibitors that target the interaction of YAP1 with OCT4 | Srikumar Chellappan, Sujeewa Ranatunga Mahanthe Mudiyanselage | 2021-02-02 |
| 10813927 | Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells | Said M. Sebti, James Turkson | 2020-10-27 |
| 10806712 | Small molecule inhibitors of STAT3 with anti-tumor activity | James Turkson, Said M. Sebti, Wayne Charles Guida, Man Lun Yip, Harshani R. Lawrence +1 more | 2020-10-20 |
| 10738016 | BRD4-kinase inhibitors as cancer therapeutics | Ernst Schönbrunn, Harshani R. Lawrence | 2020-08-11 |
| 10526291 | Potent dual BRD4-kinase inhibitors as cancer therapeutics | Ernst Schönbrunn, Harshani R. Lawrence, Gary Reuther | 2020-01-07 |
| 10494389 | STAT3 dimerization inhibitors | Said M. Sebti, Harshani R. Lawrence | 2019-12-03 |
| 10336734 | Inhibitors of ACK1/TNK2 tyrosine kinase | Nupam P. Mahajan, Kiran N. Mahajan, Harshani R. Lawrence | 2019-07-02 |
| 10226439 | Small molecule inhibitors of STAT3 with anti-tumor activity | James Turkson, Said M. Sebti, Wayne Charles Guida, Man Lun Yip, Harshani R. Lawrence +1 more | 2019-03-12 |
| 10106507 | Potent dual BRD4-kinase inhibitors as cancer therapeutics | Ernst Shönbrunn, Harshani R. Lawrence | 2018-10-23 |
| 10017478 | Inhibitors of ACK1/TNK2 tyrosine kinase | Nupam P. Mahajan, Kiran N. Mahajan, Harshani R. Lawrence | 2018-07-10 |
| 9968599 | Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells | Said M. Sebti, James Turkson | 2018-05-15 |